FDA NDC Directory · JSON-LD · Markdown

Eribulin Mesylate

NDC 0781-3391 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic nameeribulin mesylate
Labeler / ManufacturerSandoz Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA214310
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsERIBULIN MESYLATE (.5 mg/mL)
Marketing started20250707
Package count1

External sources

Source: openFDA. Public-domain (CC0).